PTC THERAPEUTICS INC's ticker is PTCT and the CUSIP is 69366J200. A total of 208 filers reported holding PTC THERAPEUTICS INC in Q1 2021. The put-call ratio across all filers is 0.07 and the average weighting 0.2%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q2 2023 | $23,278 | -20.1% | 572,353 | -4.8% | 0.33% | -21.4% |
Q1 2023 | $29,116 | +15.7% | 601,083 | -8.9% | 0.42% | +18.7% |
Q4 2022 | $25,175 | -99.9% | 659,540 | -9.9% | 0.36% | -29.9% |
Q3 2022 | $36,741,000 | +33.7% | 731,890 | +6.7% | 0.51% | +33.4% |
Q2 2022 | $27,477,000 | -13.2% | 685,900 | -19.2% | 0.38% | +7.9% |
Q1 2022 | $31,654,000 | -26.6% | 848,405 | -21.7% | 0.36% | -7.1% |
Q4 2021 | $43,132,000 | +2.6% | 1,082,905 | -4.2% | 0.38% | +4.1% |
Q3 2021 | $42,043,000 | -13.8% | 1,129,885 | -2.1% | 0.37% | -8.0% |
Q2 2021 | $48,770,000 | -0.7% | 1,153,785 | +11.2% | 0.40% | -5.2% |
Q1 2021 | $49,124,000 | -23.5% | 1,037,470 | -1.4% | 0.42% | -19.2% |
Q4 2020 | $64,196,000 | +18.2% | 1,051,868 | -9.4% | 0.52% | +2.6% |
Q3 2020 | $54,296,000 | +7.5% | 1,161,418 | +16.6% | 0.51% | +5.4% |
Q2 2020 | $50,522,000 | +22.0% | 995,695 | +7.3% | 0.48% | -2.4% |
Q1 2020 | $41,415,000 | +37.5% | 928,375 | +48.0% | 0.49% | +83.6% |
Q4 2019 | $30,128,000 | – | 627,270 | – | 0.27% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
GREAT POINT PARTNERS LLC | 1,750,000 | $84,053,000 | 7.32% |
RTW INVESTMENTS, LP | 3,832,480 | $184,074,000 | 6.94% |
Burrage Capital Management LLC | 195,725 | $9,401,000 | 6.30% |
Asymmetry Capital Management, L.P. | 55,408 | $2,661,000 | 4.77% |
SECTORAL ASSET MANAGEMENT INC | 328,738 | $15,789,000 | 2.36% |
ARMISTICE CAPITAL, LLC | 758,000 | $36,407,000 | 2.10% |
INTERNATIONAL BIOTECHNOLOGY TRUST PLC | 114,000 | $5,470,000 | 1.97% |
Opaleye Management Inc. | 191,000 | $9,174,000 | 1.80% |
Sofinnova Investments, Inc. | 517,092 | $24,836,000 | 1.79% |
Chubb Ltd | 8,180 | $393,000 | 1.68% |